ArticleMedical journal, Armed Forces India
Resveratrol as an add on therapy to sertraline in animal models of depression.
Article in Medical journal, Armed Forces India. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sertraline, a selective serotonin reuptake inhibitor, is a leading antidepressant. Resveratrol is a natural polyphenol with diverse biological activities, including antidepressant-like effects. In this study we evaluated the individual and combined antidepressant effects of resveratrol and sertraline alongwith effect of resveratrol on sertraline serum levels. Methods: Tail Suspension Test (TST) and Forced Swim Test (FST) were used to study the antidepressant effect in adult male albino mice which were divided into 5 groups. Group 1 was treated with sertraline, group 2 with resveratrol, group 3 and 4 with sertraline (different doses) and resveratrol, and group 5 was given vehicle control only. Serum sertraline levels were estimated by high performance liquid chromatography (HPLC). Mean increase in time to immobility in TST and mean reduction in immobility in FST of the animal(s) were compared. Results: Combination of sertraline and resveratrol demonstrated the maximum antidepressant effect followed by sertraline and resveratrol only groups. Serum sertraline levels were higher in the combination group as compared to sertraline only group. Conclusion: Resveratrol demonstrated antidepressant effects in this study and also had an additive effect on the effect of sertraline. It's addition also increased serum sertraline levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.